novel protein, TAP2-HLA-DOB readthrough (TAP2-HLA-DOB)

The TAP2-HLA-DOB readthrough refers to a genomic event where transcription continues from the TAP2 gene through the adjacent HLA-DOB locus, potentially resulting in a hybrid transcript. Although both TAP2 and HLA-DOB individually encode important proteins in the major histocompatibility complex involved in antigen presentation, there is no robust evidence that the readthrough encodes a functional or clinically relevant protein product. Consequently, this entity is not considered a validated molecular target, and its biological significance remains unestablished.

No drugs or inhibitors with described mechanism of action for the readthrough.